Shandong Provincial Hospital
252
60
72
44
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
2.4%
6 terminated/withdrawn out of 252 trials
88.0%
+1.5% vs industry average
21%
54 trials in Phase 3/4
0%
0 of 44 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (252)
Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China
Role: collaborator
Thyroxine Supplementation in Small for Gestational Age (SGA) Infants With Birth Weight <1500g and TSH 6-20 mIU/ml
Role: lead
Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)
Role: collaborator
TACE Combined With Thermal Ablation and ADC, PD-1, and Chemotherapy as First-line Treatment for HER2-highly-expressing Gastric Cancer With Liver Metastases: A Multicenter, Single-arm Prospective Clinical Study.
Role: lead
Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer
Role: collaborator
LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia
Role: collaborator
Safety and Efficacy of Early Brain-Computer Interface Training After Reperfusion Therapy in Acute Ischemic Stroke
Role: lead
A Phase II Study of NB001 for Acute Migraine Treatment
Role: collaborator
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Role: collaborator
Postoperative Adjuvant Therapy for Stage II-III Gastric Cancer
Role: collaborator
An Artificial Intelligence System for Multimodal, Multi-class Diagnosis of Pancreatic Cystic Lesions Based on Endoscopic Ultrasonography
Role: collaborator
Effectiveness of Detachment of the Breathing Circuit on the Rate of DLT Malposition After Postural Change
Role: lead
A Multicenter Randomized Controlled Phase II Trial of Iparomlimab and Tuvonralimab (QL1706) Combined With SOX Chemotherapy Versus Chemotherapy Alone in the Treatment of Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Role: lead
Clinical Study of Low-dose Interval Radiotherapy Combined With Tirelizumab and SOX Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Role: lead
Efficacy and Safety of Tislelizumab Plus Chemotherapy as Conversion Therapy in Unresectable Locally Advanced ESCC
Role: lead
Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial Large-Vessel Occlusion
Role: lead
Laparoscopic Staging for Stage III Gastric Cancer
Role: collaborator
Cardiac Magnetic Resonance-Clinical Prediction Model-Dilated Cardiomyopathy
Role: lead
Blood mNGS for Diagnosing Invasive Pulmonary Fungal Disease in Hematologic Patients
Role: collaborator
Observational Study on Dynamic Changes of Blood Pressure During Post-epileptic Seizure Stage (OCBPS)
Role: collaborator